首页   >  
Angiogenesis/Protein Tyrosine Kinase
  >  
Src/Bcr Abl
  >   Elzovantinib
Elzovantinib 结构式

Elzovantinib

参考资料 仅供科学研究,不可用于个人用途。
货号 :BCP40929CAS号 :2271119-26-5纯度:98%
全国免运费!免费咨询:400-099-8200 或 手机联系:13472751340
即时询价 ×

* 必填项

请填妥以下表格,您将在一分钟内得到邮件机器人给你的报价。

Product name

 

* Applicant name

Catalog Number

 

* Institution/Company

* Email address

 

Phone number

Country

 

* Quantity Required

Remarks

Inquiry Online ×

* Required Fields.

Please complete the form below and we will contact you shortly.

Product name

 

* Applicant name

Catalog Number

 

* Institution/Company

* Email address

 

Phone number

Country

 

* Quantity Required

Remarks

Bulk Inquiry ×

* Required Fields.

Please complete the form below and we will contact you shortly.

Product name

 

* Applicant name

Catalog Number

 

* Institution/Company

* Email address

 

Phone number

Country

 

* Quantity Required

Remarks

  • 基本信息与产品描述
CAS号 2271119-26-5 货号 BCP40929
中文名 Elzovantinib
英文名 Elzovantinib
中文别名
英文别名 TPX-0022; TPX 0022; TPX0022;CSF1R-IN-2;
SMILES CCN1CC2=C(C=CC(=C2C#N)F)OC(CNC(=O)C3=C4N=C1C=CN4N=C3N)C
化学名称
分子式 C20H20FN7O2 分子量 409.42
纯度 98% 配送 惯例下常温包邮
产品描述 TPX-0022, also known as CSF1R-IN-2, is an orally bioavailable multi-targeted kinase inhibitor with a novel three-dimensional macrocyclic structure that inhibits the MET, CSF1R (colony stimulating factor 1 receptor) and SRC kinases. Targeting CSF1R leads to the modulation of tumor-associated macrophages (TAMs), a type of immune cell that suppresses the T-cell mediated anti-tumor immune response. Inhibition of CSF1R with TPX-0022 is a promising therapeutic strategy as a single agent or in combination with standard of care chemotherapy and immunotherapy in various solid tumors.
  • 技术资料和支持
在购买和使用瀚香生物产品的过程中,您遇到的任何问题,都可以咨询我们的免费热线:400-099-8200,或者和我们的客服 。 我们竭诚解决您的一切疑惑,保证您的舒心顺畅。

相关产品推荐

查看更多 >

Tags:Elzovantinib 供应商,Elzovantinib 购买,Elzovantinib 生产,Elzovantinib 批量,Elzovantinib 供应,Elzovantinib 订购,Elzovantinib 采购

2853530910